Licensed Practical Nurse in Waterloo, IA Accepting Medicare

6 Licensed Practical Nurse nurses found. Showing 1 - 6

Julie Anna Shepard, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 604 Lafayette St, Waterloo, IA 50703 Phone: 833-370-0719

Mr. Mark Thomas Haberer, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3251 W 9th St, Waterloo, IA 50702 Phone: 319-234-2893    Fax: 319-234-0354

Mrs. Abby Irene Kolthoff, ARNP Licensed Practical Nurse Medicare: Medicare Enrolled Practice Location: 3251 W 9th St, Waterloo, IA 50702 Phone: 319-234-2893    Fax: 319-234-0354

Chrishandia White, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1410 Lyon Ave, Waterloo, IA 50702 Phone: 319-429-2640

Sonja Navarro, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1742 Lark Ln, Waterloo, IA 50701 Phone: 319-252-0405

Ms. Terri Lynn Smith, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 3251 W 9th St, Waterloo, IA 50702 Phone: 319-234-2893    Fax: 319-234-0354

News Archive

House passes student loan plan that siphons health law's prevention trust fund

The student loan issue has become a politically charged showdown with the health law in the middle of the controversy.

Heart protein saves muscle

A heart muscle protein can replace its missing skeletal muscle counterpart to give mice with myopathy a long and active life, show Nowak et al. The findings will be published online on Monday, May 25, 2009 and will appear in the June 1, 2009 print issue of the Journal of Cell Biology.

Rights Issue to be carried out by keeping the authorization by the Annual General Meeting, resolves Tripep

The Board of Directors of Tripep AB (publhas on the 27th of November 2009, based on the authorization by the Annual General Meeting resolved to carry out a rights issue.

Infinity and AbbVie enter into global collaboration to develop and commercialize duvelisib

Infinity Pharmaceuticals, Inc. and AbbVie Inc. today announced that they have entered into a global collaboration to develop and commercialize duvelisib (IPI-145), Infinity's oral inhibitor of phosphoinositide-3-kinase (PI3K)-delta and PI3K-gamma, for the treatment of patients with cancer.

Read more Medical News

› Verified 6 days ago